Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

Blood
Esther A ObengLawrence H Boise

Abstract

Multiple myeloma (MM) is an incurable plasma cell malignancy. The 26S proteasome inhibitor, bortezomib, selectively induces apoptosis in MM cells; however, the nature of its selectivity remains unknown. Here we demonstrate that 5 different MM cell lines display similar patterns of sensitivity to 3 proteasome inhibitors (PIs) but respond differently to specific NF-kappaB inhibition. We further show that PIs initiate the unfolded protein response (UPR), a signaling pathway activated by the accumulation of misfolded proteins within the endoplasmic reticulum (ER). Consistent with reports that prosurvival/physiologic UPR components are required for B-cell differentiation into antibody-secreting cells, we found that MM cells inherently expressed the ER chaperones GRP78/Bip and GRP94/gp96. However, bortezomib rapidly induced components of the proapoptotic/terminal UPR, including PERK, the ER stress-specific eIF-2alpha kinase; ATF4, an ER stress-induced transcription factor; and its proapoptotic target, CHOP/GADD153. Consistent with our hypothesis that PIs induce the accumulation of misfolded ER-processed proteins, we found that the amount of immunoglobulin subunits retained within MM cells correlated with their sensitivity to PIs. The...Continue Reading

Associated Clinical Trials

Dec 2, 2011·Scott E Smith, MD, PhD, Scott E Smith, MD, PhD

References

Aug 27, 1990·Biochimica Et Biophysica Acta·J W HersheyJ Schnier
Apr 1, 1989·Molecular and Cellular Biology·M Kostura, M B Mathews
Mar 13, 1986·Biochemical and Biophysical Research Communications·T TamaokiF Tomita
Nov 24, 1983·Nature·I G Haas, M Wabl
Aug 1, 1995·Current Opinion in Cell Biology·C Hammond, A Helenius
Oct 6, 1995·Cell·C L WardR R Kopito
Oct 7, 1994·Cell·A Ciechanover
Oct 14, 1996·Biochemical and Biophysical Research Communications·M V BlagosklonnyW S el-Deiry
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·E D WernerA A McCracken
Jul 8, 1997·Biochemistry·T M LoftusE J Stanbridge
Aug 26, 1998·European Journal of Biochemistry·Y KawazoeK Nagata
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·J AdamsR L Stein
Jan 28, 1999·Biochemical and Biophysical Research Communications·D KimG C Li
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·J W BrewerJ A Diehl
Aug 5, 1999·The Biochemical Journal·S SatohK Shimotohno
Dec 3, 1999·Science·L EllgaardA Helenius
Dec 3, 1999·Science·M Ibba, D Söll

❮ Previous
Next ❯

Citations

Apr 25, 2012·Cancer Immunology, Immunotherapy : CII·Hui-Ming ChenNing-Sun Yang
Sep 26, 2009·Cancer Chemotherapy and Pharmacology·Metin KurtogluTheodore J Lampidis
Aug 21, 2009·Basic Research in Cardiology·Jozef Leo Van HerckArnold G Herman
Apr 4, 2009·Targeted Oncology·Efstathios KastritisMeletios A Dimopoulos
Sep 11, 2009·Leukemia·J J Shah, R Z Orlowski
Aug 2, 2008·Nature Reviews. Immunology·Derrich J ToddLaurie H Glimcher
Jun 4, 2010·Nature Reviews. Rheumatology·Iñaki Sanz, F Eun-Hyung Lee
Mar 31, 2007·Cell Death and Differentiation·L EggerD E Bredesen
Dec 1, 2007·Cell Death and Differentiation·A Strasser, H Puthalakath
Jan 12, 2008·Cell Death and Differentiation·D MasedaR E Voll
Aug 24, 2006·Leukemia·J A F MarteijnB A van der Reijden
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Qiuyan WangYihong Ye
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kristopher A SarosiekIzidore S Lossos
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tsui-Fen ChouRaymond J Deshaies
Apr 2, 2011·The Journal of Biological Chemistry·Alyson J SmithScott H Kaufmann
Sep 16, 2009·The Journal of Experimental Medicine·Derrick J ToddLaurie H Glimcher
Feb 15, 2011·Antioxidants & Redox Signaling·Franziska KriegenburgRasmus Hartmann-Petersen
Feb 23, 2007·Molecular Biology of the Cell·Mikael LernerOlle Sangfelt
Jul 7, 2009·Cardiovascular Research·Nadia Hedhli, Christophe Depre
Sep 7, 2006·Journal of the National Cancer Institute·Yuki IshiiDoris Germain
Dec 9, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nicholas BarnettNizam Mamode
Sep 22, 2006·Current Opinion in Oncology·Paul G RichardsonKenneth Anderson
Apr 9, 2009·Transplantation·Eliot C HeherNelson B Goes
Jan 18, 2013·Journal of Virology·Birte Kalveram, Tetsuro Ikegami
Nov 28, 2007·Annual Review of Pathology·Jonathan H LinT S Benedict Yen
Oct 7, 2011·Journal of Oncology·Marc J BraunsteinOlcay Batuman
Jun 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marc A WenigerAdrian Wiestner

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis